Subscribe to RSS
DOI: 10.1055/s-2004-815447
© Georg Thieme Verlag KG Stuttgart · New York
Cancer Chemopreventive Activity of Rotenoids from Derris trifoliata
This study was supported in part by Grants-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science, and the High-Tech Research Center Project from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. This study was also supported in part by a grant from the National Cancer Institute (CA17625).Prof. Masataka Itoigawa
Tokai Gakuen University
Ukigai
Miyoshi-cho
Nishikamo-gun
Aichi 470-0207
Japan
Phone: +81-5613-6-5555
Fax: +81-5613-6-6757
Email: itoigawa@tokaigakuen-u.ac.jp
Publication History
Received: June 16, 2003
Accepted: November 8, 2003
Publication Date:
01 July 2004 (online)
Abstract
A study of the chemical constituents of the stems of Derris trifoliata Lour. (Leguminosae) led to the isolation and identification of one new rotenoid, 6aα,12aα-12a-hydroxyelliptone (3), together with five other known rotenoids. In a search for novel cancer chemopreventive agents (anti-tumor promoters), we carried out a primary screening of five of the rotenoids isolated from the plant for their inhibitory effects on Epstein-Barr virus early antigen (EBV-EA) activation induced by 12-O-tetradecanoylphorbol 13-acetate (TPA) in Raji cells. The inhibitory activity of 3 was found to be equivalent to that of β-carotene without any cytotoxicity. Deguelin (4) and α-toxicarol (5) exhibited a marked inhibitory effect on mouse skin tumor promotion in an in vivo two-stage carcinogenesis test. This investigation indicated that rotenoids might be valuable anti-tumor promoters.
Key words
Derris trifoliata - Leguminosae - rotenoid - cancer chemopreventive agents - anti-tumor promoters
Introduction
Rotenone and related compounds, isolated from the roots of plants such as Derris (Leguminosae), were originally used to paralyze fish before being used as an insecticide [1]. Rotenoids are known not only as toxicants, but also as candidate anticancer agents. Rotenoids have been shown to exhibit extremely potent cytotoxicity against six human cancer cell lines [2]. Deguelin (4), one of the rotenoids, has also been shown to mediate strong inhibition of 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced ornithine decarboxylase (ODC) activity in cell culture and to reduce the activity in the two-stage 7,12-dimethylbenz[a]anthracene (DMBA)/TPA skin carcinogenesis model with mice and rats [3], [4], [5], [6]. Furthermore, we have previously reported that some rotenoids including tephrosin (6; Fig. [1]) isolated from plants of the Leguminosae family showed strong inhibitory effects on Epstein-Barr virus early antigen (EBV-EA) activation induced by the tumor promoter TPA, and exhibited significant anti-tumor promotion effects on mouse skin tumors in an in vivo two-stage carcinogenesis test [7]. In this paper, we describe the isolation and identification of one new rotenoid, 6aα,12aα-12a-hydroxyelliptone (3), from the stems of D. trifoliata Lour. We also report the inhibitory effects of rotenoids isolated from the plant on EBV-EA activation and in vivo two-stage carcinogenesis of mouse skin.

Fig. 1 Structures of rotenoids from Derris trifoliata.
Materials and Methods
#General experimental procedures
1H- and 13C-NMR, COSY, HMQC, HMBC (J = 8 Hz), and NOE were measured on JNM A-400, A-600 and/or ECP-500 (JEOL) spectrometers. Chemical shifts are shown in δ (ppm) with tetramethylsilane (TMS) as an internal reference. All mass spectra were taken using electron impact (EI) ionization, unless otherwise stated, using an HX-110 (JEOL), and/or a JMS-700 (JEOL) spectrometer with a direct inlet system. UV spectra were recorded on a UVIDEC-610C double-beam spectrophotometer (JASCO) in MeOH, IR spectra on an IR-230 (JASCO) in CHCl3, optical rotations on a DIP-370 (JASCO) in CHCl3 at 25 °C, and CD spectra on a J-600 (JASCO) in MeOH. Preparative TLC was performed on Kieselgel 60F254 (Merck).
#Plant materials
The plant materials used in this study, Derris trifoliata Lour. (Leguminosae), were collected in August 1995. Dr H.T.W. Tan identified the material using keys or by comparison with herbarium sheet specimens at the Herbarium, Department of Biological Sciences, The National University of Singapore (SINU) or at the Herbarium, Botanic Gardens, Singapore (SING). A voucher specimen has been deposited at SINU under number H.T.W. Tan 6 - 1995. The plant is used as a stimulant, antispasmodic and counter-irritant in Singapore.
#Extraction and isolation
The dried stems (135 g) of D. trifoliata were extracted with acetone (2 L × 3) at room temperature and the solvent was evaporated under reduced pressure to give the acetone extract (6.5 g), which was subjected to silica gel (l50 g) column chromatography eluted with hexane-acetone (17 : 3, 4 : 1, 7 : 3, 3 : 2, 1 : 1, 3 : 7), acetone, CH2Cl2-MeOH (3 : 1) and MeOH gradients (each 0.5 L), successively to obtain fractions 1 - 9. Fraction 2 (hexane-acetone, 4 : 1, 298 mg) was chromatographed on silica gel (10 g) and eluted with hexane-acetone (85 : 15 → 60 : 40, 150 mL for each eluent) yielding 4 (13.8 mg) and 5 (11.0 mg), which were purified by preparative TLC with CH2Cl2, respectively. Fraction 3 (hexane-acetone, 7 : 3, 622 mg) was chromatographed on silica gel (12g) and eluted with hexane-acetone (85 : 15 → 50 : 50, 200 mL for each eluent) yielding 4 (27.9 mg), 5 (7.5 mg) and 6 (l2.5 mg). Fraction 4 (hexane-acetone, 3 : 2, 812 mg) was subjected to column chromatography on silica gel (12 g), and elution with hexane-acetone (90 : 10 → 50 : 50, 200 mL for each eluent) to afford 2 (22.2 mg), which was purified by preparative TLC with benzene-MeOH (96 : 4). Fraction 5 (hexane-acetone, 1 : 1, 1.0 g) was chromatographed on silica gel (15g) and elution with hexane-acetone (80 : 20 → 40 : 60) afforded 1 (21.5 mg) and 3 (12.6 mg), which were purified by preparative TLC with hexane-EtOAc (80 : 20) and benzene-acetone (94 : 6), respectively.
6aα,12aα-12a-Hydroxyelliptone (3): Colorless oil; [α]D 25: -4.4° (c 0.068, CHCl3); IR (CHCl3): νmax = 3504, 1678, 1614 cm-1; UV (MeOH): λmax (log ε) = 203 (4.57), 239 (4.46), 277 (3.85), 292 sh (3.70), 319 (3.47) nm; CD (MeOH): [Θ]235 = -11 758, [Θ]239 = -7617, [Θ]244 = -10 621, [Θ]252 = -3796, [Θ]262 = -5962, [Θ]274 = 0, [Θ]295 = 9725, [Θ]325 = 2943, [Θ]343 = 0, [Θ]355 = -1766, [Θ]369 = 0; 1H-NMR (CDCl3, 400 MHz): δ = 7.87 (1H, d, J = 8.8 Hz, H-11), 7.56 (1H, d, J = 2.2 Hz, H-2′), 7.17 (1H, dd, J = 1.1, 8.8 Hz, H-10), 6.91 (1H, dd, J = 1.1, 2.2 Hz, H-3′), 6.55 (1H, s, H-1), 6.49 (1H, s, H-4), 4.74 (1H, br s, H-6a), 4.72 (1H, dd, J = 14.3, 2.6 Hz, H-6), 4.56 (1H, d, J = 14.3 Hz, H-6), 4.49 (1H, br s, 12a-OH), 3.80 (3H, s, 3-OCH3), 3.71 (3H, s, 2-OCH3); 13C-NMR (CDCl3,100 MHz): δ = 192.2 (s, C-12), 160.6 (s, C-9), 155.8 (s, C-7a), 151.2 (s, C-3), 148.4 (s, C-4a), 145.1 (d, C-2′), 144.0 (s, C-2), 123.9 (d, C-11), 117.2 (s, C-8), 112.0 (s, C-11a), 109.3 (d, C-1), 108.4 (s, C-12b), 107.1 (d, C-10), 104.8 (d, C-3′), 101.1 (d, C-4), 77.2 (d, C-6a), 67.7 (s, C-12a), 63.8 (t, C-6), 56.4 (q, 2-OCH3), 55.8 (q, 3-OCH3); Differential NOE: Irradiation of 3-OCH3 (δ = 3.80) -19 % enhancement of H-4 (δ = 6.49), irradiation of 2-OCH3 (δ = 3.71) -11 % enhancement of H-1 (δ = 6.55); El-MS: m/z = 368 [M+] (31), 208 [M+ - C9H4O3] (base peak), 193 (9), 165 (10), 160 [M+ - C11H12O4] (9); HR-MS: m/z = 368.0913 (calcd. for C20H16O7 : 368.0895).
#In vitro EBV-EA activation experiment
Raji cells in the exponential growth phase were maintained in RPMI-1640 medium (Sigma Chemical Co., MI, USA) supplemented with 10 % fetal bovine serum, harvested by centrifugation and resuspended. To test the effect of the candidate compounds, each concentration of the candidate compounds was added to the Raji cells in medium supplemented with 32 pmol TPA and 4 mM n-butyric acid, and incubated for 48 h at 37 °C. After incubation, each sample was centrifuged at 1,000 g for 10 min and the precipitates were resuspended in PBS and placed on a 76 × 26 mm micro slide glass (Matsunami Glass Ind., Ltd, Tokyo). The smear samples were stained with NPC serum and human IgG serum to examine their specific activation. The activated early antigens were detected by immunohistochemical studies using fluorescence microscopy. The treated cells were observed with trypan blue staining for cell cytotoxicity. For the determination of cytotoxicity, the cell viability was required to be more than 60 % 2 days after treatment with the compounds for an accurate result.
#In vivo two-stage mouse skin carcinogenesis test
Female ICR mice were obtained at 5 - 6 weeks of age from SLC Co. Ltd (Shizuoka, Japan). Groups of 15 mice were housed in subgroups of five in polycarbonate cages. Mice were permitted free access to MP solid diet (Oriental yeast Co., Ltd., Chiba, Japan) and drinking water at all times during the study. The back of each mouse was shaved with surgical clippers before the first day of tumor initiation. Tumors on the back of the mice were initiated with DMBA (390 nmol) in acetone (0.1 mL). One week after initiation, the tumors were promoted by twice weekly application of TPA (1.7 nmol) in acetone (0.1 mL). Rotenoid-treated mice were treated with the test compounds (85 nmol) in acetone (0.1 mL) 1 h before each TPA treatment. The incidence of papillomas was observed weekly for 20 weeks. Positive control mice were given topical application of acetone to the same portion of the back as promoter treatment 1 h before TPA application, and rotenoids were also given by the same treatment instead of acetone.
#Results and Discussion
The acetone extract of stems of D. trifoliata was fractionated by silica gel column chromatography and preparative TLC to obtain one new rotenoid, 6aα,12aα-12a-hydroxyelliptone (3) as a colorless oil, [α]D 25: -4.4° (c 0.068, CHCl3) and its molecular formula was determined as C20H16O7 by HR-MS. The UV spectrum of 3 was similar to that of elliptone (2). The IR spectrum exhibited bands at νmax = 3504 and 1678 cm-1 due to hydroxy and conjugated carbonyl groups. The MS fragmentation peaks occurred at m/z = 208 (base peak, M+ - ·C9H4O3) and 160 (9 %, M+ - ·C11H12O4) via a retro Diels-Alder process in ring C. The 1H-NMR spectrum of 3 exhibited two singlet methoxy groups (δ = 3.80 and 3.71) and four aromatic protons [two ortho-coupled protons (δ = 7.87, 7.17) and two singlet protons (δ = 6.55, 6.49)]. It also exhibited the following signals due to protons on carbon atoms bearing oxygen atoms: δ = 4.74 (H-6a), 4.72 (H-6), and 4.56 (H-6). In addition, the characteristic signals of two benzofuranoic protons (δ = 7.56 and 6.91) were observed along with a D2O exchangeable proton (δ = 4.49, OH). Location of the methoxy groups at C-2, C-3 was indicated by observation of NOEs between a methoxy at δ = 3.80 and an aromatic singlet proton at δ = 6.49 (H-4) and between another methoxy at δ = 3.71 and an aromatic singlet proton at δ = 6.55 (H-l). The presence of a hydroxy group at C-12a was indicated by HMBC, which showed a significant C-H three-bond correlation between a carbonyl carbon at δC = 192.2 (C-12) and a hydroxy proton at δ = 4.49 (Fig. [2]) coupled with the MS fragmentations. The H-1 chemical shift value (δ = 6.55) indicated that the B/C ring junction of 3 was cis [8]. The determination of the absolute configuration of 12a-hydroxyrotenoids by CD spectroscopy was studied by Tahara et al. [9]. 12a-Hydroxyrotenone and villosinol having [6aR,12aR] stereochemistry were reported to show positive Cotton effects at 359 nm and 348 nm and negative Cotton effects at 335 nm and 303 nm, respectively. And 12a-hydroxyerythynone having [6aS,12aS] has been known to show a negative Cotton effect at 370 nm and a positive Cotton effect at 332 nm [9]. From analysis of the CD spectrum, 3 was found to give a negative Cotton effect at 355 nm and a positive Cotton effect at 325 nm, therefore the B/C ring absolute stereochemistry was assigned to be [6aS,12aS] [9], [10]. On the basis of these data, the structure of 6aα,12aα-12a-hydroxyelliptone (3) was determined to be as shown in Fig. [1].
Recently, the isolation of the (+)-isomer of 3 from D. malaccensis was reported [11]. Five known rotenoids, rotenone (1), elliptone (2), deguelin (4), α-toxicarol (5), and (-)-tephrosin (6), were also isolated and were identified by comparison of their spectral data with those published in the literature [12]. The absolute configuration of (-)-tephrosin (6), isolated from the seeds of Millettia dura (Dunn), remained unchanged [10]. As to the consideration of the CD spectrum of 6, a positive Cotton effect ([Θ] + 894) at 357 nm and a negative Cotton effect ([Θ] -13 157) at 327 nm were observed; therefore the B/C ring absolute stereochemistry was determined as [6aR,12aR]. Further examination of the constituents of this plant is now in progress.
Five natural rotenoids (1 - 5) were tested for their anti-tumor-promoting activity by using a short-term in vitro assay of TPA-induced EBV-EA activation in Raji cells. The inhibitory effects of these rotenoids on the activation of the virus-genome, and the viabilities of Raji cells, are shown in Table [1]. All tested rotenoids were found to show inhibitory activity on the EBV activation even at a 1 × 10 mol ratio, and showed a significant inhibitory effect at high concentrations (1 × 103 mol ratio). However, all rotenoids showed only weak cytotoxicity in assays of Raji cells even at the 1 × 103 mol ratio. The inhibitory effects of rotenoids 1 - 5 were more potent than that of β-carotene, a vitamin A precursor commonly used as a reference in cancer prevention studies [13], at 1 × 102 and 1 × 10 mol ratios (23.2 - 33.6 % and 3.2 - 5.3 % inhibition of activation, respectively). At 1 × 103 and 5 × 102 mol ratios, rotenoids 1 - 5 showed equivalent or weaker inhibitory effects (86.1 - 100.0 % and 53.8 - 62.6 %, respectively) than that of β-carotene.
Deguelin (4) and α-toxicarol (5) are the major components in the stems of D. trifoliate while the tumor inhibitory activity of deguelin (4) in the mouse skin carcinogenesis model has already been reported by Udeani et al. [4]. In the present study, we demonstrated the inhibitory effect of α-toxicarol (5) to compare it with the effect of deguelin (4) on an in vivo skin carcinogenesis model. At 10 weeks after DMBA-TPA tumor promotion, the incidence of papillomas was 100 % in the control animals. In comparison, the incidence of papillomas in the group pre-treated with α-toxicarol (5) was markedly reduced by 73 and 33 % after 10 and 15 weeks of promotion, respectively (Fig. [3] A). As shown in Fig. [3] B, the number of papillomas per mouse was reduced by about 63 and 34 % after 10 and 20 weeks in α-toxicarol (5) pre-treated mice, respectively, compared to untreated mice. These results suggest that α-toxicarol (5) showed about the same inhibitory activity as deguelin (4) (Figs. 3 A and 3 B), and these rotenoids might be valuable as potential cancer chemopreventive agents (anti-tumor promoters). Intensive investigations on the structure-activity relationship of the rotenoids, and also studies investigating the mechanism of their inhibitory activities, are now in progress.

Fig. 2 C-H long-range correlations in the HMBC spectrum of 6aα,12aα-12a-hydroxyelliptone (3). Bold lines: more significant correlations in the structure determinations.

Fig. 3 Inhibitory effects of rotenoids on DMBA-TPA mouse skin carcinogenesis. Tumors were initiated in all mice with DMBA (390 nmol) and promoted with TPA (1.7 nmol) twice weekly starting 1 week after initiation. A Percentage of mice with papillomas. B Average number of papillomas per mouse. •, control TPA alone; ○, TPA + 85 nmol of deguelin (4); □, TPA + 85 nmol of α-toxicarol (5). After 20 weeks of tumor promotion, the number of papillomas per mouse differed between the rotenoid-treated groups and the control group (p < 0.05).
Compound | EBV-EA-positive cells (% viability) | |||
Compound concentration (mol ratio/32 pmol TPA) | ||||
1 000 | 500 | 100 | 10 | |
Rotenone (1) | 0.0 ± 0.7 (60) | 37.4 ± 1.2 (>80) | 69.2 ± 1.7 (>80) | 95.7 ± 0.9 (>80) |
Elliptone (2) | 13.9 ± 0.3 (60) | 46.2 ± 1.2 (>80) | 76.8 ± 2.2 (>80) | 96.8 ± 0.2 (>80) |
6aα,12aα-12a-Hydroxyelliptone (3) | 11.9 ± 0.7 (60) | 42.3 ± 1.1 (>80) | 66.4 ± 1.6 (>80) | 94.7 ± 0.4 (>80) |
Deguelin (4) | 9.5 ± 0.3 (60) | 44.8 ± 1.9 (>80) | 72.3 ± 1.1 (>80) | 96.8 ± 0.6 (>80) |
α-Toxicarol (5) | 7.3 ± 0.7 (60) | 43.0 ± 0.8 (>80) | 71.9 ± 2.0 (>80) | 94.7 ± 0.6 (>80) |
β-Carotene* | 9.1 ± 0.5 (60) | 34.3 ± 1.1 (>80) | 82.7 ± 1.8 (>80) | 100.0 ± 0.2 (>80) |
Mol ratio/TPA (32 pmol = 20 ng/mL), 1000 mol ratio = 32 nmol, 500 mol ratio = 16 nmol, 100 mol ratio = 3.2 nmol, and 10 mol ratio = 0.32 nmol. Values are EBV-EA activation (%) ± s. d. in the presence of the test compound relative to the positive control (100 %). Values in parentheses represent the surviving Raji cells measured by trypan blue staining. A minimum 60 % survival rate of Raji cells 2 days after treatment with the compounds is required for an accurate result. | ||||
* Positive control substance. |
References
- 1 Kan W S. Manual of Medicinal Plants in Taiwan. Vol. 2 National Research Institute of Chinese Medicine Taiwan; 1972: pp 276-80
- 2 Li L, Wang H K, Chang J J, McPhail A T, McPhail D R, Terada H. et al . Antitumor agents, 138. Rotenoids and isoflavones as cytotoxic constituents from Amorpha fruticosa . Journal of Natural Products. 1993; 56 690-8
- 3 Udeani G O, Zhao G M, Shin Y G, Kosmeder JW 2 nd, Beecher C WW, Kinghorn A D. et al . Pharmacokinetics of deguelin, a cancer chemopreventive agent in rats. Cancer Chemotherapy and Pharmacology. 2001; 47 263-8
- 4 Udeani G O, Gerhäuser C, Thomas C F, Moon R C, Kosmeder J W, Kinghorn A D. et al . Cancer chemopreventive activity mediated by deguelin, a naturally occurring rotenoid. Cancer Research. 1997; 57 3424-8
- 5 Gerhäuser C, Lee S K, Kosmeder J W, Moriarty R M, Hamel E, Mehta R G. et al . Regulation of ornithine decarboxylase induction by deguelin, a natural product cancer chemopreventive agent. Cancer Research. 1997; 57 3429-35
- 6 Gerhäuser C, Mar W, Lee S K, Suh N, Luo Y, Kosmeder J. et al . Rotenoids mediate potent cancer chemopreventive activity through transcriptional regulation of ornithine decarboxylase. Nature Medicine. 1995; 1 260-6
- 7 Konoshima T, Terada H, Kokumai M, Kozuka M, Tokuda H, Estes J R. et al . Studies on inhibitors of skin tumor promotion, XII. Rotenoids from Amorpha fruticosa . Journal of Natural Products. 1993; 56 843-8
- 8 Lin L -J, Ruangrungsi N, Cordell G A, Shieh H- L, You M, Pezzuto J M. 6-Deoxyclitoriacetal from Clitoria macrophylla . Phytochemistry. 1992; 31 4329-31
- 9 Tahara S, Narita E, Ingham J L, Mizutani J. New rotenoids from the root bark of Jamaican dogwood (Piscidia erythrina L.) Zeitschrift fur Naturforschung. 1990; 45c 154-60
- 10 Ollis W D, Rhodes C A, Sutherland I O. The extractives of Millettia dura (Dunn). The constitutions of durlettone, durmillone, milldurone, millettone and millettosin. Tetrahedron. 1967; 23 4741-60
- 11 Thasana N, Chuankamnerdkarn M, Ruchirawat S. A new 12a-hydroxyelliptone from the stems of Derris malaccensis . Heterocycles. 2001; 55 1121-5
- 12 Carlson D G, Weisleder D, Tallent W H. NMR investigations of rotenoids. Tetrahedron. 1973; 29 2731-41
- 13 Murakami A, Ohigashi H, Koshimizu K. Anti-tumor promotion with food phytochemicals: A strategy for cancer chemoprevention. Bioscience Biotechnology and Biochemistry. 1996; 60 1-8
Prof. Masataka Itoigawa
Tokai Gakuen University
Ukigai
Miyoshi-cho
Nishikamo-gun
Aichi 470-0207
Japan
Phone: +81-5613-6-5555
Fax: +81-5613-6-6757
Email: itoigawa@tokaigakuen-u.ac.jp
References
- 1 Kan W S. Manual of Medicinal Plants in Taiwan. Vol. 2 National Research Institute of Chinese Medicine Taiwan; 1972: pp 276-80
- 2 Li L, Wang H K, Chang J J, McPhail A T, McPhail D R, Terada H. et al . Antitumor agents, 138. Rotenoids and isoflavones as cytotoxic constituents from Amorpha fruticosa . Journal of Natural Products. 1993; 56 690-8
- 3 Udeani G O, Zhao G M, Shin Y G, Kosmeder JW 2 nd, Beecher C WW, Kinghorn A D. et al . Pharmacokinetics of deguelin, a cancer chemopreventive agent in rats. Cancer Chemotherapy and Pharmacology. 2001; 47 263-8
- 4 Udeani G O, Gerhäuser C, Thomas C F, Moon R C, Kosmeder J W, Kinghorn A D. et al . Cancer chemopreventive activity mediated by deguelin, a naturally occurring rotenoid. Cancer Research. 1997; 57 3424-8
- 5 Gerhäuser C, Lee S K, Kosmeder J W, Moriarty R M, Hamel E, Mehta R G. et al . Regulation of ornithine decarboxylase induction by deguelin, a natural product cancer chemopreventive agent. Cancer Research. 1997; 57 3429-35
- 6 Gerhäuser C, Mar W, Lee S K, Suh N, Luo Y, Kosmeder J. et al . Rotenoids mediate potent cancer chemopreventive activity through transcriptional regulation of ornithine decarboxylase. Nature Medicine. 1995; 1 260-6
- 7 Konoshima T, Terada H, Kokumai M, Kozuka M, Tokuda H, Estes J R. et al . Studies on inhibitors of skin tumor promotion, XII. Rotenoids from Amorpha fruticosa . Journal of Natural Products. 1993; 56 843-8
- 8 Lin L -J, Ruangrungsi N, Cordell G A, Shieh H- L, You M, Pezzuto J M. 6-Deoxyclitoriacetal from Clitoria macrophylla . Phytochemistry. 1992; 31 4329-31
- 9 Tahara S, Narita E, Ingham J L, Mizutani J. New rotenoids from the root bark of Jamaican dogwood (Piscidia erythrina L.) Zeitschrift fur Naturforschung. 1990; 45c 154-60
- 10 Ollis W D, Rhodes C A, Sutherland I O. The extractives of Millettia dura (Dunn). The constitutions of durlettone, durmillone, milldurone, millettone and millettosin. Tetrahedron. 1967; 23 4741-60
- 11 Thasana N, Chuankamnerdkarn M, Ruchirawat S. A new 12a-hydroxyelliptone from the stems of Derris malaccensis . Heterocycles. 2001; 55 1121-5
- 12 Carlson D G, Weisleder D, Tallent W H. NMR investigations of rotenoids. Tetrahedron. 1973; 29 2731-41
- 13 Murakami A, Ohigashi H, Koshimizu K. Anti-tumor promotion with food phytochemicals: A strategy for cancer chemoprevention. Bioscience Biotechnology and Biochemistry. 1996; 60 1-8
Prof. Masataka Itoigawa
Tokai Gakuen University
Ukigai
Miyoshi-cho
Nishikamo-gun
Aichi 470-0207
Japan
Phone: +81-5613-6-5555
Fax: +81-5613-6-6757
Email: itoigawa@tokaigakuen-u.ac.jp

Fig. 1 Structures of rotenoids from Derris trifoliata.

Fig. 2 C-H long-range correlations in the HMBC spectrum of 6aα,12aα-12a-hydroxyelliptone (3). Bold lines: more significant correlations in the structure determinations.

Fig. 3 Inhibitory effects of rotenoids on DMBA-TPA mouse skin carcinogenesis. Tumors were initiated in all mice with DMBA (390 nmol) and promoted with TPA (1.7 nmol) twice weekly starting 1 week after initiation. A Percentage of mice with papillomas. B Average number of papillomas per mouse. •, control TPA alone; ○, TPA + 85 nmol of deguelin (4); □, TPA + 85 nmol of α-toxicarol (5). After 20 weeks of tumor promotion, the number of papillomas per mouse differed between the rotenoid-treated groups and the control group (p < 0.05).